What Is the Evidence for Rasburicase in Tumor Lysis Syndrome?
Tumor lysis syndrome (TLS) is not uncommon on the oncology ward. A novel agent, rasburicase, has been used to treat the uric acid nephropathy with some success. A recent [...]
Copyright © 2023 Powered by WordPress.com.